Showing results (231-240 of 503) with videos related to
Sort By:
Pageof 51
Journal of the National Cancer Institute|April 22, 2026
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediatorsSabrina E Wang, Vivian Viallon, Carine Biessy, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and CancerJ M Genkinger, K Wu, M Wang, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 15, 2022
Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood MeasurementsKarl Smith-Byrne, Agustin Cerani, Florence Guida, et al.The Lancet. Oncology|July 30, 2013
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies, T J Key, P N Appleby, et al.American Journal of Epidemiology|March 31, 2012
Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumKonstantinos K Tsilidis, Ruth C Travis, Paul N Appleby, et al.International Journal of Cancer|November 8, 2014
Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort studyFiona McKenzie, Pietro Ferrari, Heinz Freisling, et al.Journal of the National Cancer Institute|May 15, 2014
Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survivalYin Cao, Sara Lindström, Fredrick Schumacher, et al.BMC Medicine|April 18, 2022
Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohortManon Cairat, Sabina Rinaldi, Anne-Sophie Navionis, et al.International Journal of Cancer|February 4, 2020
Theoretical potential for endometrial cancer prevention through primary risk factor modification: Estimates from the EPIC cohortRenée T Fortner, Anika Hüsing, Laure Dossus, et al.British Journal of Cancer|January 15, 2022
Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancerTrasias Mukama, Renée Turzanski Fortner, Verena Katzke, et al.Pageof 51